Comparison of encainide and quinidine for supraventricular tachyarrhythmias
- 20 December 1988
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (19) , L55-L59
- https://doi.org/10.1016/0002-9149(88)90017-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Encainide for refractory supraventricular tachycardia in childrenThe American Journal of Cardiology, 1986
- Encainide for treatment of supraventricular tachycardias associated with the Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1986
- Electrophysiology in assessing supraventricular arrhythmias: Value of programmed stimulation in predicting and understanding efficacy of encainideThe American Journal of Cardiology, 1986
- Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmiasThe American Journal of Cardiology, 1984
- Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathwayThe American Journal of Cardiology, 1984
- Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.Circulation, 1984
- Hemodynamic effects of encainide in patients with ventricular arrhythmia and poor ventricular functionThe American Journal of Cardiology, 1983
- Electrophysiology of oral encainideThe American Journal of Cardiology, 1982
- Electrophysiologic evaluation of encainide with use of monophasic action potential recordingThe American Journal of Cardiology, 1981
- The two‐period cross‐over clinical trial.British Journal of Clinical Pharmacology, 1979